Inhibiting LSD1 unlocks retinoid AP-1 programming to activate epithelial immunity and skin tumor suppression.

Saved in:
Bibliographic Details
Title: Inhibiting LSD1 unlocks retinoid AP-1 programming to activate epithelial immunity and skin tumor suppression.
Authors: Kuprasertkul N; Department of Dermatology and.; Penn Epigenetics Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Moore AF; Department of Dermatology and.; Penn Epigenetics Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., D'souza CA; Department of Dermatology and., Chini J; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics., Ko EK; Department of Dermatology and.; Penn Epigenetics Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Huang S; Penn Institute for Biomedical Informatics., Zhang S; Penn Epigenetics Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Anderson AS; Department of Dermatology and.; Penn Epigenetics Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Egolf S; Department of Dermatology and.; Penn Epigenetics Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Pinheiro LV; Department of Cancer Biology.; Abramson Family Cancer Research Institute, and., Jaccard A; Department of Cancer Biology.; Abramson Family Cancer Research Institute, and., Magahis CT; Department of Dermatology and., Bao L; Department of Dermatology and., Aubert Y; Department of Dermatology and.; Penn Epigenetics Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Olingou C; Department of Dermatology and., Prouty SM; Department of Dermatology and., Brennan-Crispi D; Department of Dermatology and., Hill DA; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics., Seykora JT; Department of Dermatology and.; Abramson Family Cancer Research Institute, and., Wellen KE; Penn Epigenetics Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Department of Cancer Biology.; Abramson Family Cancer Research Institute, and., Capell BC; Department of Dermatology and.; Penn Epigenetics Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Department of Cancer Biology.; Abramson Family Cancer Research Institute, and.; Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2026 Mar 12; Vol. 136 (8). Date of Electronic Publication: 2026 Mar 12 (Print Publication: 2026).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI189044